newsfilter
← Latest News
GlobeNewswire·

Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024

MANNHEIM, Germany, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it